MIRA INFORM REPORT

 

 

Report Date :

12.05.2008

 

 

IDENTIFICATION DETAILS

 

Name :

HAGECAPS (M) SDN BHD

 

 

Registered Office :

Suite 10.02, Bangunan Yayasan Selangor, 74, Jalan Raja Muda Abdul Aziz, 10th Floor, 50300 Kuala Lumpur, Wilayah Persekutuan, Malaysia.

 

 

Country :

Malaysia

 

 

Financials (as on) :

31.12.2007

 

 

Date of Incorporation :

24.05.2001

 

 

Com. Reg. No.:

548644-P

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacturing Empty Halal Hard Gelatin Capsule and Related Activities

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

 

 

 

 

 

 

EXECUTIVE SUMMARY

 

 

REGISTRATION NO.

:

548644-P

COMPANY NAME

:

HAGECAPS (M) SDN BHD

FORMER NAME

:

N/A

INCORPORATION DATE

:

24/05/2001

 

 

 

COMPANY STATUS

:

EXIST

LEGAL STATUS

:

PRIVATE LIMITED

LISTED STATUS

:

NO

 

 

 

 

 

 

REGISTERED ADDRESS

:

SUITE 10.02, BANGUNAN YAYASAN SELANGOR, 74, JALAN RAJA MUDA ABDUL AZIZ, 10TH FLOOR, 50300 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

BUSINESS ADDRESS

:

LOT 5365, LORONG JELAWAT 2, SEBERANG JAYA INDUSTRIAL PARK, 13700 BUTTERWORTH, PULAU PINANG, MALAYSIA.

TEL.NO.

:

04-3990259

FAX.NO.

:

04-3993259

EMAIL

:

info@hagecaps.com

WEB SITE

:

www.hagecaps.com

CONTACT PERSON

:

IBRAHIM ZAINOL ( MANAGING DIRECTOR )

 

 

 

INDUSTRY CODE

:

24230

PRINCIPAL ACTIVITY

:

MANUFACTURING EMPTY HALAL HARD GELATIN CAPSULE AND RELATED ACTIVITIES

AUTHORISED CAPITAL

:

MYR 5,000,000.00 DIVIDED INTO
ORDINARY SHARE 5,000,000.00 OF MYR 1.00 EACH.

ISSUED AND PAID UP CAPITAL

:

MYR 5,000,000.00 DIVIDED INTO
ORDINARY SHARES 2 CASH AND 4,999,998 OTHERWISE OF MYR 1.00 EACH.

 

 

 

SALES

:

MYR 1,621,861 [2007]

NET WORTH

:

MYR 57,749 [2007]

 

 

 

STAFF STRENGTH

:

20 [2008]

BANKER (S)

:

MALAYAN BANKING BHD

LITIGATION

:

CLEAR

FINANCIAL CONDITION

:

LIMITED

PAYMENT

:

N/A

MANAGEMENT CAPABILITY

:

WEAK

 

 

 

COMMERCIAL RISK

:

HIGH

CURRENCY EXPOSURE

:

MODERATE

GENERAL REPUTATION

:

SATISFACTORY

INDUSTRY OUTLOOK

:

AVERAGE GROWTH

 

HISTORY / BACKGROUND


The SC is a private limited company and is allowed to have a minimum of one and a maximum of forty-nine shareholders. As a private limited company, the SC must have at least two directors. A private limited company is a separate legal entity from its shareholders. As a separate legal entity, the SC is capable of owning assets, entering into contracts, sue or be sued by other companies. The liabilities of the shareholders are to the extent of the equity they have taken up and the creditors cannot claim on shareholders' personal assets even if the SC is insolvent. The SC is governed by the Companies Act, 1965 and the company must file its annual returns, together with its financial statements with the Registrar of Companies.

The SC is principally engaged in the (as a / as an) manufacturing empty halal hard gelatin capsule and related activities.

The SC is not listed on Bursa Malaysia (Malaysia Stock Exchange).

The SC is not qualified to be one of the Top Corporate Performers in the Malaysia 1000 (M1000) publication, a directory jointly published by Companies Commission of Malaysia (The Registrar Office), Minister of Domestic Trade and Consumer Affairs and our publication arm, BASIS Publications House Sdn Bhd.

The major shareholder(s) of the SC are shown as follows :

 

Name

Address

IC/PP/Loc No

Shareholding

MR. IBRAHIM BIN ZAINOL +

49, JALAN USJ 17/4, 47630 SUBANG JAYA, SELANGOR, MALAYSIA.

520428-02-5671 4323453

2,750,000.00

MS. NORAINI BTE CHE SAB +

49, JALAN USJ 17/4, 47630 SUBANG JAYA, SELANGOR, MALAYSIA.

590522-07-6030 5538345

2,250,000.00

 

 

 

---------------

 

 

 

5,000,000.00

 

 

 

============

 

+ Also Director

DIRECTORS

 

DIRECTOR 1

 

Name Of Subject

:

MS. NORAINI BTE CHE SAB

Address

:

49, JALAN USJ 17/4, 47630 SUBANG JAYA, SELANGOR, MALAYSIA.

IC / PP No

:

5538345

New IC No

:

590522-07-6030

Date of Birth

:

22/05/1959

 

 

 

Nationality

:

MALAYSIAN MALAY

Date of Appointment

:

24/05/2001

 

DIRECTOR 2

 

Name Of Subject

:

MR. IBRAHIM BIN ZAINOL

Address

:

49, JALAN USJ 17/4, 47630 SUBANG JAYA, SELANGOR, MALAYSIA.

IC / PP No

:

4323453

New IC No

:

520428-02-5671

Date of Birth

:

28/04/1952

 

 

 

Nationality

:

MALAYSIAN MALAY

Date of Appointment

:

24/05/2001



MANAGEMENT

 

 

 

1)

Name of Subject

:

IBRAHIM ZAINOL

 

Position

:

MANAGING DIRECTOR

 

 

 

 

 

2)

Name of Subject

:

YUSAINI SABIAN

 

Position

:

SALES MANAGER

 

 

 

 

 

3)

Name of Subject

:

MOHD IZHAR

 

Position

:

ASSISTANT PRODUCTION MANAGER

 

 

 

 

 

 

AUDITOR

 

Auditor

:

AFRIZAN TARMILI KHAIRUL AZHAR

Auditor' Address

:

BANGUNAN YAYASAN SELANGOR, 74, JALAN RAJA MUDA ABDUL AZIZ, 10TH FLOOR, 50300 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

 

 

 

 

 

 

 

COMPANY SECRETARIES

 

1)

Company Secretary

:

MS. NORMALA BTE EMBI

 

IC / PP No

:

A0046627

 

New IC No

:

650220-07-5122

 

Address

:

C-1-5, VISTA TASIK CONDOMINIUM, 12 JALAN SRI PERMAISURI, BANDAR SRI PERMAISURI, 56000 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

 

Date of Appointment

:

10/03/2008

 

 

 

 

 

 

 

 

 

2)

Company Secretary

:

MS. ZAIMIDAH BTE AB MAJID

 

 

 

 

 

New IC No

:

610420-05-5242

 

Address

:

8, JALAN BU 1/6, TAMAN BUKIT UTAMA, BUKIT ANTARABANGSA, 68000 AMPANG, SELANGOR, MALAYSIA.

 

Date of Appointment

:

10/03/2008

 

 

 

 

 

 

 

 

 

BANKING


Banking relations are maintained principally with :

1)

Name

:

MALAYAN BANKING BHD

 

 

 

 

 

The SC enjoys normal banking routine with above mentioned banker(s). No adverse record was found during our investigation.

 

ENCUMBRANCE (S)


ENCUMBRANCE 1

Date of Creation

:

19/07/2002

Description Of Charge

:

N/A

Amount Secured

:

RM3,380,000.00

Description Of Property Affected

:

N/A

Name & Address Of Chargee

:

BANK INDUSTRI TEKNOLOGI MALAYSIA BHD

 

 

 

 

Form 40 Dated

Registered and Numbered 1 In The Register of Charges

 

LEGAL CHECK AGAINST SC


* A check has been conducted in our databank againt the SC whether the subject has been involved in any litigation. Our databank consists of 99% of the wound up companies in Malaysia back dated since 1900.

No legal action was found in our databank.

No winding up petition was found in our databank.

PAYMENT RECORD

 

 

 

SOURCES OF RAW MATERIALS:

Local

:

YES

Overseas

:

YES

 

CLIENTELE

 

Local

:

YES

Percentage

:

100%

Domestic Markets

:

MALAYSIA

Overseas

:

NO

Percentage

:

0%

 

 

 

 

 

 

Credit Term

:

AS AGREED

 

 

 

 

 

 

Payment Mode

:

CHEQUES

Type of Customer

:

PHARMACIES,CLINICS,HOSPITALS,MEDICAL INDUSTRIES

 

 

 

 

 

 

 

 

 

 

 

 

OPERATIONS

 

Products manufactured

:

HALAL TWO-PIECE EMPTY HARD CAPSULES

 

 

 

Member(s) / Affiliate(s)

:

SMI ASSOCIATION OF MALAYSIA

 

 

 

 

Total Number of Employees:

 

YEAR

2008

2007

2006

2005

 


GROUP

N/A

N/A

N/A

N/A

 

 

 

 

 

COMPANY

20

18

15

12

 

 

 

 

 

 

Branch

:

NO

Other Information:


The SC is principally engaged in the (as a / as an) manufacturing empty halal hard gelatin capsule and related activities.

The SC's high quality capsules are manufactured to the highest standard and are suitable for various applications. Each and every capsule is manufactured to exact customer's requirements and suitable for filling likes;

* Pharmaceutical active ingredients

* Herbal and traditional madecines ingredients

* Food supplements

The SC's capsules can takes fillings in form of;

* Normal powder

* Compacted powders

* Oil based liquids (liquid capsule filling machine with sealer required)

The SC's capsules comes in varoius basic colours from Trans Clear/Trans Clear, Trans Blue/Trans Clear, Red/White, Black/Scarlet, Maroon/Maroon, Green/White, Ivory/Ivory to Orange/Orange, Blue/White etc. However as colour combinations are numerous, it is up to the SC's customers specification of colour requirements.

The SC's high quality coloured capsules or clear capsules are suiteble for uses in pharmaceutical, supplement as well as herbal/traditional madecines.

Besides that the SC will print customised text and/or logo on the capsules based on its customers' requirements.

The SC's high quality 2-piece hard capsules are produced from high quality raw materials certified halal by JAKIM and free from any kind of preservatives.

The SC only use halal gelatin from Rousselot manufactured in their halal certified facility in Guandong, China. This factory has been inspected and certified by China Halal Authority, Malaysia's JAKIM and Malaysia's Department of Veterinary Services.

This halal gelatine is also approved by the Australian Quarantine and Inspection Services (AQIS) and the European Directorate for the Quality of Medicines (EDQM).

We were informed that the SC put great emphasize on treacability on each and every capsule that manufacture, from it own batch to the gelatin batch, right to the slaughterhouse and the farms the cattle are from.



The SC has invested heavily on a one of the kind, state-of-the-art facility to manufacture 2-piece hard capsules in Malaysia.

PROJECTS


No projects found in our databank

RECENT DEVELOPMENT


26 JUNE 2007

Welli Multi Corp Bhd, which plans to build the world's largest halal gelatine plant by year-end, is no longer buying a stake in SC, currently Malaysia's only halal-certified gelatine capsule manufacturer. Nonetheless, Welli Multi chief executive officer Dr Abdul Rashid Tang Abdullah said the termination does not change the company's plan to build its halal gelatin plant. "We will apply for halal certification for our plant," Abdul Rashid told The Edge Financial Daily, while adding that details on the plant would be released in "a few days". In a statement to Bursa Malaysia yesterday, Welli Multi said the agreement to buy a proposed 65% stake in SC from Ibrahim Zainol had been "terminated with immediate effect by mutual consent" as both parties could not agree on the terms to be included in the final agreement, it added. On May 24, Welli Multi said it agreed to pay RM1.63 million for the 65% stake in SC. The price represents five times its share of expected earnings from SC this year. Loss-making SC expects to book RM500,000 in profit on revenue of RM3 million this year.

CURRENT INVESTIGATION

Latest fresh investigations carried out on the SC indicated that :

Telephone Number Provided By Client

:

N/A

Current Telephone Number

:

04-3990259

Match

:

N/A

 

 

 

Address Provided by Client

:

LOT 5365, LORONG JELAWAT 2, SEBERANG JAYA INDUSTRIAL PARK, 13700 BUTTERWORTH, PULAU PINANG.

Current Address

:

LOT 5365, LORONG JELAWAT 2, SEBERANG JAYA INDUSTRIAL PARK, 13700 BUTTERWORTH, PULAU PINANG, MALAYSIA.

Match

:

YES

 

 

 

Latest Financial Accounts

:

YES

 

Other Investigations


We conducted an interview with Ms Rohani from the SC's Admin Department. She revealed some information pertaining to the SC.

FINANCIAL COMMENTS

 

 

The financial summary of the SC in Year 2007 showed that it was financially LIMITED. Return on shareholders' funds of the SC was high indicating that the SC was efficient in utilising its shareholders' funds to generate favourable returns. However, due to its weak liquidity position, the SC will be face with problems in meeting all its short term obligations if no short term loan is obtained or additional capital injected into the SC. The SC has high liabilities ratio and it may face financial difficulties if no additional capital is injected.

Overall financial condition of the SC : LIMITED

ECONOMIC / INDUSTRY OUTLOOK

 

Major Economic Indicators:

2004

2005

2006

2007*

2008**

 

 

 

 

 

 

Population ( Million)

25.58

26.13

26.64

27.17

27.73

Gross Domestic Products ( % )

7.1

5.3

5.8

6.3

6.5

Domestic Demand ( % )

7.5

7.3

7.0

9.0

6.8

Private Expenditure ( % )

13.1

9.5

7.0

8.6

8.2

Consumption ( % )

10.5

9.2

7.1

9.0

7.9

Investment ( % )

25.8

8.5

7.0

7.1

9.5

Public Expenditure ( % )

<2.1>

3.6

6.8

10.1

3.2

Consumption ( % )

6.0

5.4

5.0

10.8

5.5

Investment ( % )

<8.7>

1.9

8.9

9.3

0.5

 

 

 

 

 

 

Balance of Trade ( MYR Million )

80,663

99,760

108,192

99,965

99,599

Government Finance ( MYR Million )

<19,419>

<18,684>

<19,109>

<19,948>

<20,933>

Government Finance to GDP / Fiscal Deficit ( % )

<4.3>

<3.8>

<3.3>

<3.2>

<3.1>

Inflation ( % Change in Composite CPI)

1.4

3.1

3.9

4.0

4.0

Unemployment Rate

3.5

3.5

3.4

3.5

3.3

 

 

 

 

 

 

Net International Reserves ( MYR Billion )

254

266

290

-

-

Average Risk-Weighted Capital Adequacy Ratio ( % )

13.84

13.63

12.91

-

-

Average 3 Months of Non-performing Loans ( % )

8.46

6.74

5.41

-

-

Average Base Lending Rate ( % )

5.99

6.00

6.61

-

-

Business Loans Disbursed( % )

10.5

8.7

<2.5>

-

-

Foreign Investment ( MYR Million )

13,143.9

17,882.9

20,228.0

-

-

Consumer Loans ( % )

-

-

-

-

-

 

 

 

 

 

 

Registration of New Companies ( No. )

38,580

37,474

38,293

-

-

Registration of New Companies ( % )

6.8

<2.9>

2.2

-

-

Liquidation of Companies ( No. )

3,334

3,069

8,647

-

-

Liquidation of Companies ( % )

<15.8>

<7.9>

181.8

-

-

 

 

 

 

 

 

Registration of New Business ( No. )

189,206

193,095

216,147

-

-

Registration of New Business ( % )

4.6

2.1

11.9

-

-

Business Dissolved ( No. )

51,301

73,355

52,879

-

-

Business Dissolved ( % )

7.0

43.0

<27.9>

-

-

 

 

 

 

 

 

Sales of New Passenger Cars (' 000 Unit )

380.6

400.8

374.1

-

-

Cellular Phone Subscribers ( Million )

14.6

18.5

19.5

21.3

-

Tourist Arrival ( Million Persons )

15.7

16.7

17.5

20.1

-

Hotel Occupancy Rate ( % )

60.8

63.6

64.8

-

-

 

 

 

 

 

 

Credit Cards Spending ( % )

19.3

13.9

15.4

-

-

Bad Cheque Offenders (No.)

70,465

57,316

36,555

-

-

Individual Bankruptcy ( No.)

16,251

15,868

13,596

-

-

Individual Bankruptcy ( % )

31.6

<2.4>

<14.3>

-

-

 

 

 

 

 

 

 

INDUSTRIES ( % of Growth ):

2004

2005

2006

2007*

2008**

 

 

 

 

 

 

Agriculture

5.0

2.5

5.3

3.1

3.4

Palm Oil

3.9

7.1

5.8

<0.6>

-

Rubber

16.5

<2.9>

12.6

1.0

-

Forestry & Logging

4.3

2.0

<0.4>

2.8

-

Fishing

5.5

<0.4>

9.3

5.2

-

Other Agriculture

2.4

3.2

5.3

7.0

-

Industry Non-Performing Loans ( MYR Million )

620.3

563.7

516.5

487.3

0

% of Industry Non-Performing Loans

1.38

1.19

1.06

1.08

0

 

 

 

 

 

 

Mining

3.9

0.8

<0.4>

3.3

6.0

Oil & Gas

4.5

1.6

4.6

-

-

Other Mining

<8.0>

<1.0>

5.1

-

-

Industry Non-performing Loans ( MYR Million )

62.6

68.8

55.4

42.2

-

% of Industry Non-performing Loans

0.1

0.1

0.1

0.1

-

 

 

 

 

 

 

Manufacturing #

9.8

5.1

7.3

3.1

1.8

Exported-oriented Industries

15.5

3.0

11.1

<1.9>

-

Electrical & Electronics

17.8

3.6

13.4

3.0

-

Rubber Products

14.8

2.4

0.4

8.0

-

Wood Products

12.7

0.9

0.7

3.3

-

Textiles & Apparel

<11.7>

<4.4>

12.6

<10.1>

-

Domestic-oriented Industries

9.7

6.9

5.0

5.3

-

Food, Beverages & Tobacco

3.8

7.7

4.8

5.6

-

Chemical & Chemical Products

14.6

6.9

1.7

9.2

-

Plastic Products

13.5

18.6

21.3

<3.6>

-

Iron & Steel

2.7

<6.7>

<6.9>

17.5

-

Fabricated Metal Products

29.2

<7.5>

20.0

26.2

-

Non-metallic Mineral

<4.8>

<6.0>

<1.9>

6.6

-

Transport Equipment

8.6

10.4

5.3

<19.0>

-

Paper & Paper Products

2.3

4.6

4.1

14.9

-

Crude Oil Refineries

<2.4>

8.2

12.1

8.6

-

Industry Non-Performing Loans ( MYR Million )

7,765.4

6,035.6

6,181.3

6,366.2

-

% of Industry Non-Performing Loans

17.3

12.7

12.7

14.1

-

 

 

 

 

 

 

Construction

<1.5>

<1.6>

<0.5>

5.2

5.5

Industry Non-Performing Loans ( MYR Million )

5,547.7

5,172.7

5,527.3

5,116.7

-

% of Industry Non-Performing Loans

12.4

10.9

11.4

11.3

-

 

 

 

 

 

 

Services

6.8

6.6

7.2

9.0

7.7

Electric, Gas & Water

8.1

5.5

5.2

4.6

5.0

Transport, Storage & Communication

8.5

6.3

5.2

7.6

7.8

Wholesale, Retail, Hotel & Restaurant

7.1

8.0

7.1

11.6

10.0

Finance, Insurance & Real Estate

6.3

7.0

7.7

10.7

9.2

Government Services

6.5

7.6

9.8

4.6

8.6

Other Services

4.9

5.0

4.7

5.0

5.9

Industry Non-Performing Loans ( MYR Million )

8,913.7

8,716.8

11,593.2

10,207.8

-

% of Industry Non-Performing Loans

19.9

18.4

23.9

22.6

-

 

 

 

 

 

 

 

 

 

 

 

 

* Estimate / Preliminary

 

 

 

 

 

** Forecast

 

 

 

 

 

# Based On Manufacturing Production Index
(Source : Department of Statistics / Economic Report / Bank Negara Report)

 

 

 

 

 

 



 

 

 

INDUSTRY COMMENTS

 

MSIC CODE

24230 : Manufacture of pharmaceuticals, medicinal chemicals and botanical products

 

 

INDUSTRY :

PHARMACEUTICAL

 

 

 


The market for the pharmaceutical industry is growing due to increased public awareness about health matters, resulting in greater spending on healthcare. The pharmaceutical industry in Malaysia has good growth potential in the light of its inherent strength in the production of generic drugs and its capability to capitalize on the scheduled patent expiry of several branded drugs over the next few years. The industry is also well-positioned to produce more pharmaceuticals of international quality as the country has adopted and enforced the Good Manufacturing Practice (GMP) standards of the European Pharmaceutical Inspection Cooperation Scheme (PICS).

 


In 2006, pharmaceutical companies invested substantially to upgrade their facilities to adhere to the GMP standards of PICS. These efforts, aimed at raising the standards of locally manufactured pharmaceuticals, will have favourable impact on export potential for local manufacturers as newer versions of generic drugs are launched in the next few years. Exports in 2006 (January-November) amounted to RM410 million.


The pharmaceutical market in South East Asia and China estimated at USD20.1 billion. However, zooming in on the local pharmaceutical industry, there are several structural weaknesses including the sector's inability to compete effectively with low-cost generic drugs producers in India and China, coupled with the rising production cost due to increasing compliance expenditure.


Nonetheless, in 2006, it was announced that a Health Tourism Unit will be established under the Ministry of health service in Malaysia. The number of foreign patients treated in private hospitals under the health tourism programme is envisaged to record a healthy growth of 35.3% in 2006 with over 75% patients from Indonesia, 6% from Japan, 3% from Europe and the rest from India, Singapore, Australia, China and the US.


The growth prospects for the pharmaceutical and healthcare sector are positive, underpinned by rising awareness and affluence of the population. In particular the private healthcare sector has experienced continuous growth since the beginning of 90s. The Malaysian health care system is divided into two sectors; the public and the private health care sector. Both health care sectors are still to be expanded and bear a high potential for growth. Currently approximately 3% of the GDP are dedicated towards the health care sector. For 2006, the government has announced to allocate about US $0.4 billion (RM1.3 billion ) for development expenditure to the Ministry of Health, up 8.3%from RM1.2 billion a year ago.

 

 

OVERALL INDUSTRY OUTLOOK : Average Growth

 

 

 

 

 

COMMENTS

 


Incorporated in 2001, the SC is a private limited company, focusing on manufacturing of empty halal hard gelatin capsule and related activities. Throughout its years of establishment, the SC has slowly been building up contacts with its clients and competing in the industry. We noted that the SC's issued and paid up capital has increased to RM5 million. Thus, the SC should has the ability to further expand its business in the future.


The SC solely concentrates on the local market only. This narrow market segment limits its business expansion opportunities and placed the SC at higher business risk. The SC should venture into the international market to expand its business. At present, the SC has 20 staff in its operation and it's daily operation is overseen by its Managing Director, Ibrahim Zainal. Its management capability is considered weak.


For the financial year ended 2007, the SC registered a pre-tax profit of RM240,785 based on its turnover of RM1,621,861. The SC has generated a favourable return based on its existing shareholders' funds which indicated that the management was efficient in utilising its funds to generate income. However, we noted that the SC's current liabilities well exceed its current assets. Due to its weak liquidity position, the SC may face working capital deficiency in meeting its short term financial obligations if no fresh capital are injected into the SC. The high gearing ratio clearly implied that the SC was supported by more debt than equity. Thus, the SC is exposed to high financial risk. The SC's overall financial performance is regarded as limited as its networth stands at only RM57,749


The SC's suppliers are from local market and also from overseas market. As a result, the SC is exposed to foreign currency fluctuation risk.


Investigation revealed that the SC is clear of litigation.


The market for the pharmaceutical industry is growing due to increase public awareness about health matters, resulting in greater spending on healthcare. With the promising outlook of the industry performance, the SC business potential should be favourable. The SC however faces moderate business risk as it has to compete with many well established players in the same field.


Despite showing an increasing of its paid up capital, we noted that the SC's has huge accumulated losses of RM2.44 million. In view of this and based on our assessment, we recommend credit be granted to the SC with guarantee.

 

 

 

 

 

 

 

 

 

 

 

THE FINANCIAL STATEMENTS WERE PREPARED IN ACCORDANCE WITH MALAYSIA ACCOUNTING STANDARD.

 

PROFIT AND LOSS ACCOUNT

HAGECAPS (M) SDN BHD

31-December-2007

 

Consolidated Accounts

:

NO

UnQualified Reports

:

YES

 

 

 

RM

Turnover

1,621,861.00

Operating Revenue

0.00

 

---------------------

Profit/(Loss) Before Tax

240,785.00

 

---------------------

 

Profit/(Loss) After Tax

240,785.00

Extraordinary Item

0.00

Minority Interest

0.00

 

---------------------

Profit/(Loss) Attributable to Shareholders

240,785.00

 

---------------------

 

Prior Period Adjustment

0.00

Net Dividend

0.00

Transferred To/From Reserved

0.00

Others

0.00

 

---------------------

Unappropriated Profit/(Loss) Brought Forward

<2,683,036.00>

 

---------------------

Unappropriated Profit/(Loss) Carried Forward

<2,442,251.00>

 

================

 

 

BALANCE SHEET

HAGECAPS (M) SDN BHD

31-December-2007

 

Consolidated Accounts

:

NO

UnQualified Reports

:

YES

 

 

 

RM

Fixed Assets

6,256,987.00

Total Investment

0.00

Amount Owing By

0.00

Current Assets

633,073.00

Intangible Assets

0.00

Other Assets

0.00

 

---------------------

Total Assets

6,890,060.00

 

================

 

 

Working Capital

<2,831,777.00>

 

 

Issued Capital

2,500,000.00

Paid Up Capital

2,500,000.00

Share Premium & Reserved

0.00

Unappropriated Profit/(Loss)

<2,442,251.00>

 

---------------------

Shareholder's Fund/Equity

57,749.00

 

---------------------

 

Current Liabilities

3,464,850.00

Amount Owing To

0.00

Long-term and Deferred Liabilities

3,367,461.00

Share Application Account

0.00

Minority Interest

0.00

 

---------------------

Total Equity Liability

6,890,060.00

 

================

 

 

Contingent Liabilities

0.00



 

 

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions